3D Diagnostic Imaging Services Market Report: Trends, Forecast and Competitive Analysis to 2030

3D Diagnostic Imaging Services Trends and Forecast

The future of the global 3D diagnostic imaging services market looks promising with opportunities in the diagnostic center, hospital, and research center markets. The global 3D diagnostic imaging services market is expected to reach an estimated $257.81 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases, rising need for early diagnosis, and technological advancements in 3D imaging modalities.

A more than 150-page report is developed to help in your business decisions.

3D Diagnostic Imaging Services by Segment

The study includes a forecast for the global 3D diagnostic imaging services by technique, application, end use industry, and region.

3D Diagnostic Imaging Services Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

• Ultrasound
• MRI
• X-ray
• Computed Tomography
• Others

3D Diagnostic Imaging Services Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Oncology
• Cardiology
• Orthopedic
• Others

3D Diagnostic Imaging Services Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostic Centers
• Hospitals
• Research Centers
• Others

3D Diagnostic Imaging Services Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of 3D Diagnostic Imaging Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies 3D diagnostic imaging services companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D diagnostic imaging services companies profiled in this report include-

• Laboratory Corporation
• Quest Diagnostics
• Alere
• Bio-Reference Laboratories
• Davita Healthcare Partners
• Genomic Health
• Myriad Genetics
• Neogenomics
• Sonic Healthcare Limited
• Spectra Laboratories

3D Diagnostic Imaging Services Market Insights

Lucintel forecasts that x-ray is expected to witness highest growth over the forecast period due to its increasing adoption to diagnose a wide range of conditions, including bone fractures, chest infections, and dental problems.

Within this market, hospital will remain the largest segment due to growing volume of patients who need 3D imaging services.

North America is expected to witness highest growth over the forecast period due to presence of well-developed healthcare system and growing demand for 3D imaging services.

Features of the Global 3D Diagnostic Imaging Services Market

Market Size Estimates: 3D diagnostic imaging services market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: 3D diagnostic imaging services market size by technique, application, end use industry, and region in terms of value ($B).

Regional Analysis: 3D diagnostic imaging services market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different techniques, applications, end use industries, and regions for the 3D diagnostic imaging services market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 3D diagnostic imaging services market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the 3D diagnostic imaging services market size?

Answer: The global 3D diagnostic imaging services market is expected to reach an estimated $257.81 billion by 2030.

Q.2 What is the growth forecast for 3D diagnostic imaging services market?

Answer: The global 3D diagnostic imaging services market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the 3D diagnostic imaging services market?

Answer: The major drivers for this market are growing prevalence of chronic diseases, rising need for early diagnosis, and technological advancements in 3D imaging modalities.

Q4. What are the major segments for 3D diagnostic imaging services market?

Answer: The future of the 3D diagnostic imaging services market looks promising with opportunities in the diagnostic center, hospital, and research center markets.

Q5. Who are the key 3D diagnostic imaging services market companies?

Answer: Some of the key 3D diagnostic imaging services companies are as follows:

• Laboratory Corporation
• Quest Diagnostics
• Alere
• Bio-Reference Laboratories
• DaVita Healthcare Partners
• Genomic Health
• Myriad Genetics
• NeoGenomics
• Sonic Healthcare Limited
• Spectra Laboratories

Q6. Which 3D diagnostic imaging services market segment will be the largest in future?

Answer: Lucintel forecasts that x-ray is expected to witness highest growth over the forecast period due to its increasing adoption to diagnose a wide range of conditions, including bone fractures, chest infections, and dental problems.

Q7. In 3D diagnostic imaging services market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of well-developed healthcare system and growing demand for 3D imaging services.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the 3D diagnostic imaging services market by technique (ultrasound, MRI, X-ray, computed tomography, and others), application (oncology, cardiology, orthopedic, and others), end use industry (diagnostic centers, hospitals, research centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?